Regulations/Policies - Page 2 of 27 - Express Pharma

Indian biotech start-ups: Need for pragmatic, pro-active, progressive regulatory milieu

DoP implements PLI scheme for pharmaceuticals with a financial outlay of Rs 15,000 cr

Navigating the IPR maze: India’s pharmaceutical challenge

Revised pharmacovigilance guidance for human vaccines open for public consultation

WHO, THSTI launch e-learning course on rational use of medicines for pharmacists

Pharma gives UCPMP the thumbs up, health activists cry foul

Uniform Code for Pharmaceutical Marketing Practices 2024 rolled out

DOP amends PTUAS, expands eligibility criteria to include MSMEs

Targeted funding strategies and policy interventions are key to make rare disease treatments affordable

Complying with DPDP 2023